SLISUR
LIVE

Serial Number

79357946

Owner

Gentechnologiestiftung -

Attorney

Nicholas D. Wells

Filing Date

Nov 7, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SLISUR Trademark

Serial Number: 79357946 • Registration: 7435304

SLISUR is a trademark filed by Gentechnologiestiftung - on November 7, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Gentechnologiestiftung - (3 trademarks)

Troppauer Str. 19a

Entity Type: 12

Burghardt Wittig (3 trademarks)

Salzachstr. 33

Entity Type: 01

Nucleic Acids to the Rescue GmbH (3 trademarks)

Mörfelder Landstr. 112

Entity Type: 16

Trademark Details

Filing Date

November 7, 2022

Registration Date

July 9, 2024

Published for Opposition

April 23, 2024

Goods & Services

Medical and veterinary preparations for the treatment of cancer and infectious diseases; Pharmaceuticals, namely vaccines; chemical and biological substances in the nature of oligo- and poly-nucleotides andnucleotides for medical and veterinary treatment purposes and apatamers in the nature of nucleic acid antibodiesfor medical and veterinary purposes; reagents as part of medical and veterinary preparations; chemical and biological substances in the nature of oligo- and poly-nucleotides and nucleic acid antibodies all for medical and veterinary use; reagents for medical and veterinary use; agonists for medical and veterinary use; TLR agonists for medical and veterinary use; agonists as part of medical and veterinary preparations; TLR agonists as part of medical and veterinary preparations

Chemical and biological substances in the nature of oligo- and poly-nucleotide arrays for scientific and medical research; reagents for scientific purposes; chemical and biological solvents for DNA and RNA extraction other than for medical or veterinary use; reagents for research in the field of diagnostics; chemical and biological substances in the nature of chemical and biological solvents for DNA and RNA extraction other than for medical or veterinary use; reagents for scientific or medical research use and reagents for scientific and research use

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 25, 2025 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Dec 14, 2024 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 14, 2024 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 9, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 9, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 9, 2024 R.PR
CHANGE OF OWNER RECEIVED FROM IB
Jun 21, 2024 CHLD
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 17, 2024 OPNX
CHANGE OF OWNER RECEIVED FROM IB
Jun 14, 2024 CHLD
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 15, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 15, 2024 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 23, 2024 NPUB
NOTIFICATION PROCESSED BY IB
Apr 23, 2024 GPNX
PUBLISHED FOR OPPOSITION
Apr 23, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 3, 2024 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 3, 2024 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 3, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 21, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 21, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 21, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 21, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 21, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 7, 2024 TROA
REFUSAL PROCESSED BY IB
Oct 10, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 20, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 20, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 1, 2023 RFCR
NON-FINAL ACTION WRITTEN
Aug 31, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 22, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 23, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 19, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 17, 2022 REPR